Adial Pharmaceuticals

$2.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+1.38%) As of 3:44 PM UTC today

Why Robinhood?

You can buy or sell ADIL and other stocks, options, and ETFs commission-free!

About ADIL

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist.

CEO

William B. Stilley

Employees

Headquarters

Charlottesville, Virginia

Founded

2010

Market Cap

38.17M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

178.28K

High Today

$2.23

Low Today

$2.09

Open Price

$2.20

Volume

57.81K

52 Week High

$4.00

52 Week Low

$1.14

ADIL Earnings

-$0.24

-$0.16

-$0.08

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 13, After Hours